Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
about
Diffusion-weighted MRI in neuro-oncology.Value of multi-b value DWI in the assessment of early cerebral changes in asymptomatic HIV-positive adolescents.Non-enhancing relapse of a primary CNS lymphoma with multiple diffusion-restricted lesions.Central nervous system lymphoma: characteristic findings on traditional and advanced imaging.Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease.The corpus callosum: white matter or terra incognitaCurrent strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.Acute demyelinating lesions with restricted diffusion in multiple sclerosis.Primary central nervous system lymphoma in immunocompetent patients: a retrospective review of MRI features.MR imaging features of intracranial primary CNS lymphoma in immune competent patients.Modern techniques of magnetic resonance in the evaluation of primary central nervous system lymphoma: contributions to the diagnosis and differential diagnosisDiffusion-Weighted MRI Reflects Proliferative Activity in Primary CNS Lymphoma.Diagnostic accuracy of SPECT, PET, and MRS for primary central nervous system lymphoma in HIV patients: A systematic review and meta-analysis.Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma.Application of brain multi-b-value diffusion-weighted imaging (DWI) in adolescent orphans from AIDS families.Imaging 'the lost tribe': a review of adolescent cancer imaging. Part 1.Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.Primary isolated lymphoma of the fourth ventricle in an immunocompetent patient.Restricted Diffusion of Pus in the Subarachnoid Space: MRSA Meningo-Vasculitis and Progressive Brainstem Ischemic Strokes - A Case Report.Lymphomatosis cerebri: a rare variant of primary central nervous system lymphoma and MR imaging features.Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.Apparent diffusion coefficient in glioblastoma with PNET-like components, a GBM variant.Ischemic Optic Neuropathy in a Dog with Acute Bilateral Blindness and Primary Systemic Hypertension.Diffusion-Weighted Imaging for Predicting and Monitoring Primary Central Nervous System Lymphoma Treatment Response.Combined use of 18 F-FDG PET and corticosteroid for diagnosis of deep-seated primary central nervous system lymphoma without histopathological confirmation.(1)H-MRS is useful to reinforce the suspicion of primary central nervous system lymphoma prior to surgery.The diagnostic role of (18)F-FDG PET for primary central nervous system lymphoma.Assessment of Primary Brain Lymphoma Using Multimodal Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy
P2860
Q30838362-D2C28BC9-FA5D-4D49-8943-6855FB4C7FCBQ31136296-0A2AD0BB-47A4-49AF-AEA5-23B168F34A40Q33625147-E1F8214D-65D8-4D6B-8285-CCBB323AC1B8Q33628451-0C7F3AD4-279F-44AA-8BCA-B9F4DD35FA3CQ33759799-D987607B-5E5A-4203-AF63-A70FD1BC1661Q33776523-F2932048-A8D5-40A0-A4C6-23BABB923BA9Q34072931-1AFA5A21-22D4-4899-9EFD-C12EE29CCA81Q34241405-136A49AD-C47B-4439-87B0-E824B8D6BB6FQ34304044-DB29DEEA-0C2D-4462-9B6D-640A97C1CFC1Q35093258-0E4D541F-B0B4-4F13-ABF5-1154EBCD1BC6Q35954904-70258A5E-E12D-4B5D-8E4F-0C476A37E4E7Q36115863-39995F97-F295-47D7-A3C8-EC192D79DF6BQ36367897-D31E1165-0A90-4B31-93B7-5468881B7B01Q36371802-BC30C5A2-70AD-40C1-BB37-9B1C1A43A97AQ36463751-2B6BE854-0355-4B3A-A809-1D13D47BC81EQ36839230-3A54C5F0-ECD7-41E1-8B5B-635B96E11A0FQ37471540-4BE7C1D8-88D8-4DB2-BB79-CBC9ED62BE72Q38002189-CF5C01E7-C775-40CE-A192-8D48AF3FF3CEQ39826050-056ED565-9CA9-432A-ADE7-8AC749CF2D90Q41964634-FBCE84B4-078E-4D0D-B98E-603778266651Q42371252-1AD15147-AAE9-4A3C-AA7A-BFE7AF438920Q43981672-81D77BAF-0886-4770-88EB-4C4258CC0A99Q46679261-2469F63F-ABB6-4F62-B42F-0F120C50E0DDQ47410625-367F96AF-7DA9-4427-A504-008072BFEE20Q48168887-03423A25-B126-4101-B6D0-9500FCDDC5DCQ48419607-C388A3EF-F4EA-49EB-B4AE-430C0EF055AEQ48657962-B0C01BF6-0A46-443B-BDD7-F76C84A95616Q53069155-3EAFACE4-4CC6-4D62-9429-42F77A4FF2DEQ59136582-D22606EC-49C8-428B-A4DC-A4031483CF39
P2860
Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Central nervous system lymphom ...... d imaging and MR spectroscopy.
@en
Central nervous system lymphom ...... d imaging and MR spectroscopy.
@nl
type
label
Central nervous system lymphom ...... d imaging and MR spectroscopy.
@en
Central nervous system lymphom ...... d imaging and MR spectroscopy.
@nl
prefLabel
Central nervous system lymphom ...... d imaging and MR spectroscopy.
@en
Central nervous system lymphom ...... d imaging and MR spectroscopy.
@nl
P2093
P2860
P1476
Central nervous system lymphom ...... ed imaging and MR spectroscopy
@en
P2093
Norman E Leeds
Thomas P Naidich
P2860
P304
P356
10.1111/J.1552-6569.2007.00231.X
P577
2008-05-19T00:00:00Z